News & Blog

So You Heard About Rintega? Here’s What’s Next for Brain Tumor Drug Development

Last week, news broke that a promising clinical trial of a new type of treatment for a subset of glioblastoma (GBM) patients – an immunotherapeutic vaccine made by Celldex Therapeutics called RINTEGA (rindopepimut) – was discontinued because patients receiving the investigational therapy were not doing better than patients in the control arm. As we said in our statement regarding […]

The Neuro-Oncology Field Weighs-in: Predictions & Hopes for Brain Tumor Research Advances in 2016

In 2015 we saw a major swing toward positive momentum in the fight against brain tumors, and we’re carrying it into 2016. Last year we experienced the first new treatment for newly diagnosed glioblastoma patients approved to enter the market in nearly a decade, as well as the biggest single-year increase in funding for the […]

Top Ten NBTS Blogs of 2015

2015 was a big year for brain tumor research and advocacy. Today, we’re featuring the most read blogs from 2015 that focus on breakthrough science and community stories that both raise the profile of our disease and honor those who have worked tirelessly in the fight against brain tumors; either as patients or clinicians. This […]

Share